Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation.

Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. — المؤلف: Gijbels, K — Molecular medicine (Cambridge, Mass.) 19960606

المؤلف
Gijbels, K
النشر
Molecular medicine (Cambridge, Mass.) 19960606
الوصف
795-805 p.
الموضوعات
Amino Acid Sequence؛ Animals؛ Antibodies؛ Biological Assay؛ Cell Transplantation؛ Central Nervous System؛ Disease Models, Animal؛ Encephalomyelitis, Autoimmune, Experimental